Furthermore, in line with our results transgenic overexpression of profilin-1 targeted to VSMCs caused vascular hypertrophy and hypertension in mice, and this was associated with significant increases in phospho-ERK1/2, phospho-JNK, and phospho-ROCK II kinase in mouse aortas [25]. The gene discussed is PFN1; the disease is hypertensive disorder.